Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
RECRUITINGPhase 3NCT07265284
A Study to Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Psoriasis
The purpose of this study is to evaluate the efficacy and safety of IBI112 in the treatment of adolescent participants with moderate to severe plaque-type psoriasis.
Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.Enrolling: 1041 location
Psoriasis
RECRUITINGPhase 2 / Phase 3NCT07295509
A Study of Picankibart in Patients With Active Psoriatic Arthritis
This is a multicenter, randomized, double-blind, placebo-controlled Phase II/III clinical trial evaluating the efficacy and safety of picankibart (IBI112) in patients with active...
Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.Enrolling: 2221 location
Psoriatic Arthritis